NovaBridge Biosciences: current_assets
| Value | {"amount": 750356000, "concept": "us-gaap:AssetsCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2021-12-31) |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e0a2eb24-8a7e-48f3-8217-629e2a685f21
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-22-133550Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/current-assets/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e0a2eb24-8a7e-48f3-8217-629e2a685f21
History
- supersedes {"unit": "CNY", "value": 4781718000, "concept": "us-gaap:AssetsCurrent"} (evidence 0001193125-22-133550)